SB0285 Summary

• Removes requirement to report the date controlled substances are dispensed to the Prescription Monitoring Program, while maintaining reporting of other dispensing information including quantity, days supply, and prescription fill dates.

• Modernizes electronic transmission requirements by allowing dispensers to transmit data electronically as provided by Department rule, replacing outdated methods (diskettes, magnetic tape, pharmacy claim forms).

• Requires Electronic Health Records Systems and Pharmacy Management Systems to interface with the Prescription Monitoring Program by January 1, 2024, ensuring providers have access to patient prescription records during treatment.

• Establishes that opioid treatment programs must attempt to obtain written patient consent before transmitting data to the program and prohibits using such documentation for law enforcement purposes under 42 CFR 2.

• Creates new Section 316.1 establishing requirements for integration vendors and systems, including data sharing agreements, security standards, prohibition on data storage or sale, and mandatory customer choice among approved integration vendors.